Prediction of Tacrolimus Drug Dosing and Metabolism based on CYP3A5 Polymorphism in Indian Renal Transplant Recipients

被引:0
|
作者
Patel, Mohan [1 ]
Goswami, Jitendra [3 ]
Balwani, Manish [4 ]
Gumber, Manoj [2 ]
机构
[1] Apollo Hosp, Dept Nephrol & Transplantat, Nasik, India
[2] Apollo Hosp, Dept Nephrol & Transplantat, Ahmadabad, Gujarat, India
[3] Manipal Hosp, Dept Nephrol & Transplantat, Jaipur, Rajasthan, India
[4] Jawaharlal Nehru Med Coll, Dept Nephrol & Transplantat, Sawangi, Wardha, India
关键词
D O I
10.1097/01.tp.0000542683.60190.23
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C391.2
引用
收藏
页码:S92 / S92
页数:1
相关论文
共 50 条
  • [31] CYP3A5 GENOTYPE AND TACROLIMUS DOSING REQUIREMENTS IN RENAL TRANSPLANT. CASE REPORT.
    Belen Martinez-lopez, Ana
    Blanco, Olalla Alvarez
    Lopez-fernandez, Luis A.
    Fernandez-llamazares, Cecilia M.
    Manrique-rodriguez, Silvia
    Barraca Nunez, Daniel
    Luque De Pablos, Augusto
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1726 - 1726
  • [32] Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.
    Goel, Vivek
    Malik, Manish
    Bhalla, A. K.
    TRANSPLANTATION, 2024, 108 (9S)
  • [33] Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients
    Gijsen, Violette
    Mital, Seema
    van Schaik, Ron H.
    Soldin, Offie P.
    Soldin, Steven J.
    van der Heiden, Ilse P.
    Nulman, Irena
    Koren, Gideon
    de Wildt, Saskia N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12): : 1352 - 1359
  • [34] Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.
    Goel, Vivek
    Malik, Manish
    Bhalla, A. K.
    TRANSPLANTATION, 2024, 108 (09) : 181 - 181
  • [35] Influence of CYP3A5 polymorphisms on 5-year tacrolimus pharmacokinetics and renal function in renal transplant recipients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S710 - S710
  • [36] Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients
    Kim, Jae Hyun
    Han, Nayoung
    Kim, Myeong Gyu
    Kim, Young Won
    Jang, Hayoung
    Yun, Hwi-Yeol
    Yu, Mi-Yeon
    Kim, In-Wha
    Kim, Yon Su
    Oh, Jung Mi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients
    Jae Hyun Kim
    Nayoung Han
    Myeong Gyu Kim
    Young Won Kim
    Hayoung Jang
    Hwi-Yeol Yun
    Mi-Yeon Yu
    In-Wha Kim
    Yon Su Kim
    Jung Mi Oh
    Scientific Reports, 9
  • [38] The effect of CYP3A5 polymorphism on cyclosporine plasma level in Egyptian renal transplant recipients
    Zayed B.E.M.
    Mehaney D.
    Comparative Clinical Pathology, 2015, 24 (4) : 811 - 815
  • [39] Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
    Kagaya, Hideaki
    Niioka, Takenori
    Saito, Mitsuru
    Inoue, Takamitsu
    Numakura, Kazuyuki
    Yamamoto, Ryohei
    Akamine, Yumiko
    Habuchi, Tomonori
    Satoh, Shigeru
    Miura, Masatomo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (03)
  • [40] CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
    Spierings, N.
    Holt, D. W.
    MacPhee, Iain A. M.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 328 - 331